A Cost-Effectiveness and Quality of Life Analysis of Different Approaches to the Management and Treatment of Localized Prostate Cancer

A Cost-Effectiveness and Quality of Life Analysis of Different Approaches to the Management and Treatment of Localized Prostate Cancer

The aim of this study was to compare the cost-effectiveness and quality-adjusted life years (QALYs) of active monitoring (AM), radical prostatectomy (PR), and external-beam radiotherapy with neoadjuvant hormone therapy (RT) for localized prostate cancer. Microsimulations of radical prostatectomy, 3D...

Full description

Bibliographic Details
Main Authors:	Aleksandra Harat, Maciej Harat, Melissa Martinson
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-02-01
Series:	Frontiers in Oncology
Subjects:	active monitoring cost-effectiveness analysis prostate cancer prostatectomy QALY radiotherapy
Online Access:	https://www.frontiersin.org/article/10.3389/fonc.2020.00103/full

Similar Items

Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcomes in the ProtecT randomised trial
by: S. Sanghera, et al.
Published: (2020-10-01)

Whole breast irradiation vs. APBI using multicatheter brachytherapy in early breast cancer – simulation of treatment costs based on phase 3 trial data
by: Aleksandra Harat, et al.
Published: (2016-12-01)

Dynamic Changes of Generic Quality of Life after Different Treatments for Localized Prostate Cancer
by: Yao-Lin Kao, et al.
Published: (2021-01-01)

Early stage prostate cancer: biochemical recurrence after treatment
by: Danielle A. Zanatta, et al.
Published: (2014-04-01)

Radical prostatectomy for high-risk prostate cancer | Opinion: NO
by: Saum Ghodoussipour, et al.

Radical prostatectomy for high-risk prostate cancer | Opinion: YES
by: Leonardo O. Reis, et al.

National practice patterns and direct medical costs for prostate cancer in Korea across a 10 year period: a nationwide population-based study using a national health insurance database
by: Ho Won Kang, et al.
Published: (2019-06-01)

Salvage radiotherapy for biochemical recurrence after radical prostatectomy: does the outcome depend on the prostate cancer characteristics?
by: Gustavo Arruda Viani, et al.

Editorial: Controversies and Perspectives in the Use of Postoperative Radiotherapy for Prostate Cancer
by: Alan Dal Pra, et al.
Published: (2017-11-01)

The role of metastasis-directed therapy and local therapy of the primary tumor in the management of oligometastatic prostate cancer
by: Jongchan Kim, et al.
Published: (2017-09-01)

Radical exenteration surgery is curative in locally advance mucinous prostatic adenocarcinoma involving bladder and rectum
by: Vincent S W Koo, et al.
Published: (2010-06-01)

Medical costs and quality-adjusted life years associated with smoking: a systematic review
by: Shari P. Feirman, et al.
Published: (2016-07-01)

Comparación de costes de tres tratamientos del cáncer de próstata localizado en España: prostatectomía radical, braquiterapia prostática y radioterapia conformacional externa 3D Cost comparison of three treatments for localized prostate cancer in Spain: radical prostatectomy, prostate brachytherapy and external 3D conformal radiotherapy
by: Virginia Becerra Bachino, et al.
Published: (2011-02-01)

Comparison of quality of life after stereotactic body radiotherapy and surgery for early-stage prostate cancer
by: Katz Alan, et al.
Published: (2012-11-01)

Cost-effectiveness and cost-utility analysis of tiotropium treatment for Bronchiectasis: Evidence from a cross over randomised trial
by: Coomarasamy, Christin
Published: (2018)

Preclinical evaluation of intraoperative low-energy photon radiotherapy using sphericalapplicators in locally advanced prostate cancer
by: François eBuge, et al.
Published: (2015-09-01)

Prostate cancer-specific suvival differences between radical prostatectomy and curative radiotherapy
by: DEGROOT, JULIE
Published: (2009)

Comparative analysis of radical prostatectomy techniques using perineal or suprapubic approach in the treatment of localized prostate cancer
by: Gelbert Luiz Chamon do Carmo Amorim, et al.
Published: (2010-06-01)

Critical analysis of salvage radical prostatectomy in the management of radioresistant prostate cancer
by: Daniel Seabra, et al.
Published: (2009-02-01)

Modeling-Based Decision Support System for Radical Prostatectomy Versus External Beam Radiotherapy for Prostate Cancer Incorporating an <i>In Silico</i> Clinical Trial and a Cost–Utility Study
by: Yvonka van Wijk, et al.
Published: (2021-05-01)

Methods to Estimate Willingness-to-Pay Per Quality Adjusted Life Year as Cost-Effectiveness Threshold
by: Tri Murti Andayani, et al.
Published: (2018-02-01)

Observation with or without late radiotherapy is equivalent to early radiotherapy in high-risk prostate cancer after radical prostatectomy: A SEER-Medicare analysis on trends, survival outcomes, and complications
by: Young Suk Kwon, et al.
Published: (2021-06-01)

Salvage radiotherapy of prostate cancer recurrences after radical prostatectomy
by: S. I. Tkachev, et al.
Published: (2018-04-01)

Radical prostatectomy vs radiotherapy in high-risk prostate cancer patients: two centre experience
by: Albertas Ulys, et al.
Published: (2015-01-01)

The efficacy and safety of radical prostatectomy and radiotherapy in high-risk prostate cancer: a systematic review and meta-analysis
by: Zhipeng Wang, et al.
Published: (2020-02-01)

Obesity and Surgical Treatment – A Cost-Effectiveness Assessment for Sweden
by: Sixten Borg, et al.
Published: (2014-07-01)

Results of early or delayed adjuvant radiotherapy for prostate cancer with adverse pathological tumor characteristics: A single-institute experience
by: Bo-Han Chen, et al.
Published: (2015-12-01)

Adverse effects of curative treatment of prostate cancer
by: Fridriksson, Jon Örn
Published: (2016)

Pre-radiotherapy PSA Level as a Predictor for Biochemical Control in Prostate Cancer Patients Receiving Radiotherapy after Radical Prostatectomy
by: Din-Li Tsan, et al.
Published: (2013-04-01)

Sarcopenia screening strategies in older people: a cost effectiveness analysis in Iran
by: Ali Darvishi, et al.
Published: (2021-05-01)

The role of radical prostatectomy and definitive external beam radiotherapy in combined treatment for high-risk prostate cancer: a systematic review and meta-analysis
by: Xu Cheng, et al.
Published: (2020-01-01)

Costs of conservative management of early-stage prostate cancer compared to radical prostatectomy–a claims data analysis
by: Alina Brandes, et al.
Published: (2016-11-01)

Avaliação econômica das anticitocinas adalimumabe, etanercepte e infliximabe no tratamento da artrite reumatoide no Estado do Paraná Economic evaluation of anticitokines adalimumab, etanercept and infliximab for treatment of rheumatoid arthritis in Paraná State, Brazil
by: Rafael Venson, et al.
Published: (2011-01-01)

Definitive external-beam radiotherapy versus radical prostatectomy in clinically localized high-risk prostate cancer: a retrospective study
by: Fundagul Andic, et al.
Published: (2019-01-01)

Does a previous prostate biopsy-related acute bacterial prostatitis affect the results of radical prostatectomy?
by: Hakan Türk, et al.

Retrospective study on the benefit of adjuvant radiotherapy in men with intraductal carcinoma of prostate
by: Vincent Q. Trinh, et al.
Published: (2019-04-01)

The cost-effectiveness of active surveillance compared to watchful waiting and radical prostatectomy for low risk localised prostate cancer
by: Chunhuan Lao, et al.
Published: (2017-08-01)

Salvage radical prostatectomy: an alternative treatment for local recurrence of radioresistant cancer
by: Marcos F. Dall'Oglio, et al.
Published: (2006-10-01)

Prognostic value of inflammation in prostate cancer progression and response to therapeutic: a critical review
by: Alessandro Sciarra, et al.
Published: (2016-11-01)

Difference between actual vs. pathology prostate weight in TURP and radical robotic-assisted prostatectomy specimen
by: Szilveszter Lukacs, et al.
Published: (2014-12-01)